A specialist in high-quality oligonucleotide synthesis, Syngenis has raised $4.0M to fuel its operations from Bentley Technology Park, Western Australia. The company, founded in 2020 by Prof Rakesh Veedu, provides its services to customers across Australia, New Zealand, and international markets.
Prof Veedu, a world-renowned oligonucleotide chemical biologist, brings over 15 years of experience, more than 100 publications, and several patents to Syngenis, which is staffed by highly experienced synthesis chemists.
